Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stimulant versus non-stimulant medication for ADHD with tics
ISRCTN14910154Phase 4Recruiting
- Sponsor
- University of Nottingham
- Start
- Mar 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial in attention deficit hyperactivity disorder (ADHD) and tic disorder comparing Modified-release methylphenidate arm with Guanfacine extended-release arm (2 arms). Primary endpoints: ADHD symptoms at 12 weeks and Tic severity at 12 weeks. Started Mar 2023; status: recruiting.
02
Drugs
methylphenidateguanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)tic disorder
Beyond the preview
Go deeper on ISRCTN14910154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14910154.